Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD
Public ClinicalTrials.gov record NCT03824795. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Exploratory, Open Labelled, Phase IIa Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With Clostridium Difficile-associated Diarrhea (CDAD)
Study identification
- NCT ID
- NCT03824795
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MGB Biopharma Limited
- Industry
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Interventions
- MGB-BP-3 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 6, 2019
- Primary completion
- Apr 2, 2020
- Completion
- Apr 2, 2020
- Last update posted
- Apr 14, 2020
2019 – 2020
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florida International Medical Research | Miami | Florida | 33155 | — |
| Omega Research Maitland LLC | Orlando | Florida | 32810 | — |
| Snake River Research PLLC | Idaho Falls | Idaho | 83404 | — |
| Ochsner Clinic Foundation Infectious Disease Research | New Orleans | Louisiana | 70121 | — |
| Anne Arundel Medical Centre | Annapolis | Maryland | 21401 | — |
| Mercury Street Medical Group PLLC | Butte | Montana | 59701 | — |
| Biopharma Informatic LLC | Houston | Texas | 77084 | — |
| Verity Research Inc. | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03824795, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03824795 live on ClinicalTrials.gov.